ABCG1, Down Syndrome, and Alzheimer's disease

Principal Investigator
Cheryl Wellington, BSc, PhD
University of British Columbia
Vancouver, British Columbia, Canada
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
A2006018
Summary
Cholesterol is increasingly recognized to play a role in Alzheimer’s Disease (AD), suggesting that genes that regulate cholesterol may affect the process of AD. Down Syndrome (DS) is a genetic disease caused by inheritance of an extra copy of chromosome 21. A prominent feature of DS is the inevitable development of AD by the mid-late 30s, decades earlier than the general population. Notably, chromosome 21 contains a gene known as ABCG1 that is highly expressed in brain and that is involved in cholesterol metabolism. Dr. Wellington shows that ABCG1 increases the production of Abeta peptides, which are the toxic species that accumulate in AD and DS brains. This result suggests that ABCG1 may connect cholesterol with the acceleration of AD in DS. In this proposal, Dr. Wellington will evaluate whether ABCG1 accelerates AD pathology in a mouse model and study exactly how ABCG1 works in a cell culture model system. She will also initiate studies of ABCG1 in human and mouse brain tissue as a first step in translating the results into applications for human health. This research will determine whether eventual therapies for AD may be based on ABCG1, which will be applicable for both the general and DS populations.
Grants
Related Grants
Alzheimer's Disease Research
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017
Principal Investigator
Rik Ossenkoppele, PhD
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017

Principal Investigator
Rik Ossenkoppele, PhD
Alzheimer's Disease Research
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022
Principal Investigator
Hyunjun Yang, PhD
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022

Principal Investigator
Hyunjun Yang, PhD
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD